Skip to main content
Caplight Logo









Ozette

Ozette

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://ozette.com/

Last Round

Series A

Jul 28, 2022

Total Funding Raised

$32M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ozette is a biotechnology company that provides an AI-driven single-cell immune monitoring platform designed to enhance cell discovery and annotation of the human immune system for improved patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

single-cell analysisimmune cell profilingbiotech AIcomputational immunologydrug discovery softwarebiomarker discoveryAI-powered immunologysingle-cell sequencingflow cytometry analysistranslational researchSaaS biotechAI labdigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ozette Comparables

Compare Ozette with similar companies based on industry and business-model similarity.

Ozette comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoMind
85%
BioTuring
81%
MiLaboratories
78%

Ozette Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 28, 2022
SeedFeb 16, 2021

Key People

Founding team and executive leadership

Greg Finak

Interim CEO, CTO and co-founder

Founding Team

Corrie Ortega

Chief Product Officer

Executive Team

Ozette Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 159% MoM, reaching 6.2K.

  • Jun 23, 2026

    Monthly visitors increased 55% MoM, reaching 4.5K.

Ozette Filings

Explore SEC and related filing metadata, where available.

Ozette filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ozette's valuation, stock price, and market status.

Is Ozette a public or private company?

Ozette is a private company.

What is the current stock price of Ozette?

Ozette is a private company with no public stock price. No recent secondary market data is available.

How much is Ozette worth (valuation)?

Valuation information for Ozette is not publicly available.

Can I buy Ozette stock?

Ozette shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ozette's last funding round?

Ozette's most recent funding round was Series A on July 28, 2022.

Who are the main investors in Ozette?

Key investors in Ozette include Madrona Venture Group.

Will Ozette IPO soon?

No public IPO plans have been announced for Ozette.

How can I track Ozette secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ozette's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range25
Year Founded2020
Last FundingJul 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?